Skip to main content

and
  1. Article

    Open Access

    A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers

    Trophoblast cell surface antigen 2 (Trop2) is considered to be an attractive therapeutic target in cancer treatments. We previously generated a new humanized anti-Trop2 antibody named hIMB1636, and designated ...

    Dan-dan Zhou, **ao-tian Zhai, Lan-wen Zhang, Zi-hui **e in npj Precision Oncology (2024)

  2. Article

    Open Access

    Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer

    Human epidermal growth factor receptor 2 (HER2)-positive breast cancer cases are among the most aggressive breast tumor subtypes. Accurately assessing HER2 expression status is vital to determining whether pat...

    Fang Gao, Fengxu Liu, Jun Wang, Junfang Bi in Journal of Cancer Research and Clinical On… (2024)

  3. No Access

    Article

    A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma

    Hua Wang, Bi-bo Fu, Zhi-jun Wuxiao, Ya-jun Li, Li Huang, Jie Ma, Zhi-min Zhai in Leukemia (2022)

  4. No Access

    Article

    RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines

    Epigenetic therapy has had a significant impact on the management of haematologic malignancies. The aim of this study was to assess whether 5-aza-CdR and TSA inhibit the growth of leukaemia cells and induce ca...

    Feng-**an Zhai, **ang-Fu Liu, Rui-Fang Fan in Journal of Cancer Research and Clinical On… (2012)